Loading…
No business profile yet.
Size Diamond BioFund (6901.TW) is a Taiwan Financials company (Investment Managers) with a market value of $371M, the 557th largest of 687 Taiwan companies the cockpit tracks. Shares closed at NT$14.35 on 6 Nov 2026.
Performance Over six months the shares gained 5.5%, against -11.0% for the median peer and -3.4% for the Taiwan market (cap-weighted) — 7th highest of 21 in its peer set.
Growth Revenue grew 100.0% over the last twelve months (peer median +15.5%).
Next results Next results expected around 16 Nov 2026 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | NT$0 | -NT$596,000 | NT$1.12M | NT$2.24M | NT$418,000 |
| Revenue growth | — | -153% | -50% | +437% | — |
| Gross profit | -NT$26.7M | n/a | n/a | n/a | n/a |
| EBITDA | NT$2.89B | -NT$1.25B | -NT$2.38B | -NT$2.59B | NT$890M |
| Net income | NT$2.92B | -NT$1.17B | -NT$2.52B | -NT$2.58B | NT$798M |
| Free cash flow | -NT$76.9M | -NT$166M | -NT$130M | -NT$215M | -NT$246M |
| Capital expenditure | NT$605,000 | NT$740,000 | NT$14.8M | NT$19.5M | NT$2.05M |
| Total debt | NT$81.7M | NT$93.9M | NT$118M | NT$129M | NT$3.67M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 6901.TW | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -20.3% | -1.3% | 2nd lowest of 21 |
| 6-month return | +5.5% | -11.0% | 7th highest of 21 |
| Distance from 52-week high | -35.9% | -26.9% | 7th lowest of 21 |
| Revenue growth (TTM) | +100.0% | +15.5% | 4th highest of 21 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | EV / Sales | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Diamond BioFund 6901.TW | Taiwan | $371M | +6% | +100% | n/a | n/a | n/a | n/a |
| eQ Oyj EQV1V.HE | Finland | $372M | -15% | 0% | 45% | n/a | n/a | n/a |
| Value Partners 0806.HK | Hong Kong | $367M | -26% | +164% | 39% | n/a | n/a | n/a |
| CMS Info Systems CMSINFO.NS | India | $366M | -25% | +2% | 15% | n/a | n/a | n/a |
| AlTi Global ALTI | United States | $365M | -40% | +26% | -27% | n/a | n/a | n/a |
| Australian Ethical Investment AEF.AX | Australia | $360M | +13% | +9% | 30% | n/a | n/a | n/a |
| ABC arbitrage ABCA.PA | France | $389M | +14% | +14% | 44% | n/a | n/a | n/a |
| EQT EQT.AX | Australia | $395M | +16% | -7% | 30% | n/a | n/a | n/a |
| PensionBee PBEE.L | United Kingdom | $405M | -12% | +37% | -13% | n/a | n/a | n/a |
| B.P. Marsh & Partners BPM.L | United Kingdom | $335M | +6% | +31% | 121% | n/a | n/a | n/a |
| Flat Capital FLAT-B.ST | Sweden | $413M | -10% | +2,082% | -707% | n/a | n/a | n/a |
| Kunwu Jiuding Investment 600053.SS | China | $414M | -41% | -1% | -133% | n/a | n/a | n/a |
| Deutsche Beteiligungs DBAN.DE | Germany | $414M | -23% | +5% | -29% | n/a | n/a | n/a |
| China Merchants China Direct Investments 0133.HK | Hong Kong | $416M | -15% | +81% | -99% | n/a | n/a | n/a |
| Quants Research Institute 9552.T | Japan | $325M | +59% | +36% | 29% | n/a | n/a | n/a |
| Mirae Asset Venture Investment 100790.KS | South Korea | $433M | -79% | +166% | 58% | n/a | n/a | n/a |
| Brooks Macdonald BRK.L | United Kingdom | $307M | +5% | +6% | -2% | n/a | n/a | n/a |
| OVB O4B.DE | Germany | $302M | -11% | +5% | 0% | n/a | n/a | n/a |
| First Western Financial MYFW | United States | $300M | +5% | +6% | 24% | n/a | n/a | n/a |
| Sparx 8739.T | Japan | $470M | +22% | +30% | 52% | n/a | n/a | n/a |
| Canara Robeco Asset Management CRAMC.NS | India | $473M | -11% | +17% | 62% | n/a | n/a | n/a |